ropivacaine with dexmedetomidine

PreclinicalSmall molecule

NNational Academy of Medical Sciences, Nepal

ropivacaine with dexmedetomidine is one of 20 small molecule programs targeting Postoperative Analgesia. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Postoperative AnalgesiaCompleted

Laparoscopic Abdominal SurgeryCompleted

Postoperative AnalgesiaPreclinical

Completed

Laparoscopic Abdominal SurgeryPreclinical

Completed

Competition

Competitive Landscape

24 competitors in Postoperative Analgesia

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Approved

15 2

Duragesic

CCephalon

Approved

4 3

Decadron

AAspen Global Incorporated

Approved

4 4

Nubain

AAultman Health Foundation

Approved

3 5

Celebrex

PPhiladelphia Eye Associates

Approved

1 6

EXPAREL

Pacira Pharmaceuticals, Inc

Approved

2 7

Intrathecal Morphine

Pacira Pharmaceuticals, Inc

Phase 3

5 8

Bupivacaine Only

Pacira Pharmaceuticals, Inc

Phase 3

3 9

Advil

KKenvue Brands

Phase 2

2 10

Anrikefon

ZZhujiang Hospital

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Laparoscopic Abdominal Surgery1 trial

Comparative Study on Postoperative Analgesia With Transversus Abdominis Plane Block to Local Anesthetic Infiltration With Ropivacaine in Laparoscopic Abdominal Surgery

Completed·NNational Academy of Medical Sciences, Nepal·N/A·NCT05995301·100 enrolled

Postoperative Analgesia1 trial

Caudal Ropivacaine With or Without Dexmedetomidine for Post Operative Analgesia

Completed·NNational Academy of Medical Sciences, Nepal·N/A·NCT05979558·62 enrolled

Supraclavicular Brachial Plexus Block1 trial

Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine

Completed·GGovernment Medical College, Haldwani·N/A·NCT02393677·80 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for ropivacaine with dexmedetomidine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — ropivacaine with dexmedetomidine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for ropivacaine with dexmedetomidine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — National Academy of Medical Sciences, Nepal company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: NNational Academy of Medical Sciences, Nepal

ropivacaine with dexmedetomidine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Laparoscopic Abdominal Surgery1 trial

Postoperative Analgesia1 trial

Supraclavicular Brachial Plexus Block1 trial

References

Drug Info

Quick Facts

Related News